Inhibiteur neuraminidase And NotHenju Marjuki
List of bibliographic references
Number of relevant bibliographic references: 30.Ident. | Authors (with country if any) | Title |
---|---|---|
000226 | Clyde Dapat [Japon] ; Hiroki Kondo [Japon] ; Isolde C. Dapat [Japon] ; Tatiana Baranovich [Japon] ; Yasushi Suzuki [Japon] ; Yugo Shobugawa [Japon] ; Kousuke Saito [Japon] ; Reiko Saito [Japon] ; Hiroshi Suzuki [Japon] | Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan |
000234 | PEICHEN PAN [République populaire de Chine] ; LIN LI [République populaire de Chine] ; YOUYONG LI [République populaire de Chine] ; DAN LI [République populaire de Chine] ; TINGJUN HOU [République populaire de Chine] | Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations |
000238 | Mélanie Samson [Canada] ; Andres Pizzorno [Canada] ; Yacine Abed [Canada] ; Guy Boivin [Canada] | Influenza virus resistance to neuraminidase inhibitors |
000328 | Elena A. Govorkova [États-Unis] ; Tatiana Baranovich [États-Unis] ; Patrick Seiler [États-Unis] ; Jianling Armstrong [États-Unis] ; Andrew Burnham [États-Unis] ; YI GUAN [République populaire de Chine] ; Malik Peiris [République populaire de Chine] ; Richard J. Webby [États-Unis] ; Robert G. Webster [États-Unis] | Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring |
000376 | TRONG TUAN DAO [Corée du Sud] ; THAI TRUNG DANG [Corée du Sud] ; PHI HUNG NGUYEN [Corée du Sud] ; Eunhee Kim [Corée du Sud] ; PHUONG THIEN THUONG [Namibie] ; WON KEUN OH [Corée du Sud] | Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses |
000419 | Suki Man-Yan Lee [Hong Kong] ; Hui-Ling Yen [Hong Kong] | Targeting the host or the virus: Current and novel concepts for antiviral approaches against influenza virus infection |
000480 | Miguel Delgado-Rodriguez [Espagne] ; Jesus Castilla [Espagne] ; Pere Godoy [Espagne] ; Vicente Martin [Espagne] ; Nuria Soldevita [Espagne] ; Jordi Alonso [Espagne] ; Jenaro Astray [Espagne] ; Maretva Baricot [Espagne] ; Rafael Canton [Espagne] ; Ady Castro [Espagne] ; Fernando Gonzalez-Candelas [Espagne] ; Jose María Mayoral [Espagne] ; Jose María Quintana [Espagne] ; Tomás Pumarola [Espagne] ; Sonia Tamames [Espagne] ; Marc Saez [Espagne] ; Angela Dominguez [Espagne] | Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: influence of neuraminidase inhibitors |
000534 | Ha T. Nguyen [États-Unis] ; Alicia M. Fry [États-Unis] ; Larisa V. Gubareva [États-Unis] | Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods |
000587 | Jennifer L. Mckimm-Breschkin [Australie] ; Christina Rootes [Australie] ; Peter G. Mohr [Australie] ; Susan Barrett [Australie] ; Victor A. Streltsov [Australie] | In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir |
000740 | S. Tsiodras [Grèce] ; G. Nikolopoulos [Grèce] ; S. Bonovas [Grèce] | Antivirals Used for Influenza Chemoprophylaxis : Prophylactic Treatment with Antiviral Agents ro Prevent Infection and Disease |
000744 | Ha T. Nguyen [États-Unis] ; Alma A. Trujillo [États-Unis] ; Tiffany G. Sheu [États-Unis] ; Marnie Levine [États-Unis] ; Vasiliy P. Mishin [États-Unis] ; Michael Shaw [États-Unis] ; Edwin W. Ades [États-Unis] ; Alexander I. Klimov [États-Unis] ; Alicia M. Fry [États-Unis] ; Larisa V. Gubareva [États-Unis] | Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States |
000A22 | Daniel W. Brookes [Royaume-Uni] ; Shahajahan Miah [Royaume-Uni] ; Angie Lackenby [Royaume-Uni] ; Lorian Hartgroves [Royaume-Uni] ; Wendy S. Barclay [Royaume-Uni] | Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness |
000D42 | TRONG TUAN DAO [Corée du Sud] ; PHI HUNG NGUYEN [Corée du Sud] ; HONG SIK LEE [Corée du Sud] ; Eunhee Kim [Corée du Sud] ; Junsoo Park [Corée du Sud] ; SEONG IL LIM [Corée du Sud] ; WON KEUN OH [Corée du Sud] | Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflate |
000D60 | Elena A. Govorkova [États-Unis] ; Bindumadhav M. Marathe [États-Unis] ; Ashley Prevost [États-Unis] ; Jerold E. Rehg [États-Unis] ; Robert G. Webster [États-Unis] | Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets |
000D99 | Shanta Bantia [États-Unis] ; Debra Kellogg [États-Unis] ; Cynthia Parker [États-Unis] ; Ramanda Upshaw [États-Unis] ; Natalia A. Ilyushina [États-Unis] ; Y. S. Babu [États-Unis] | A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice |
000E69 | Catherine Weil-Olivier [France] | Usage des antiviraux en pédiatrie |
000F21 | Matthew E. Falagas [Grèce, États-Unis] ; Evridiki K. Vouloumanou [Grèce] ; Evagelia Baskouta [Grèce] ; Petros I. Rafailidis [Grèce] ; Kostantinos Polyzos [Grèce] ; Jordi Rello [Espagne] | Treatment options for 2009 H1N1 influenza: evaluation of the published evidence |
001048 | Carissa E. Mancuso [États-Unis] ; Michael P. Gabay [États-Unis] ; Leah M. Steinke [États-Unis] ; Sherilyn J. Vanosdol [États-Unis] | Peramivir: An Intravenous Neuraminidase Inhibitor for the Treatment of 2009 HINI Influenza |
001449 | Jean-Pierre Vallee [France] ; Hélène Coignard [France] ; Marie Leruez [France] ; Olivier Lortholary [France] | Les inhibiteurs de la neuraminidase: Oseltamivir et zanamivir |
001496 | Elena A. Govorkova [États-Unis] ; Natalia A. Ilyushina [États-Unis, Russie] ; Jennifer L. Mcclaren [États-Unis] ; Tri S. P. Naipospos [Indonésie] ; Bounlom Douangngeun [Laos] ; Robert G. Webster [États-Unis] | Susceptibility of Highly Pathogenic H5N1 Influenza Viruses to the Neuraminidase Inhibitor Oseltamivir Differs In Vitro and in a Mouse Model |
001973 | H. Gras-Masse [France] ; N. Willand [France] | Glycochimie et thérapeutique Les inhibiteurs de neuraminidase face au risque de grippe aviaire |
001983 | John Oxford [Royaume-Uni] ; Robert Lambkin-Williams ; Alex Mann | The threat of avian influenza H5N1 : 'do we have the tools for the job?' |
001A18 | Martin Crusat [Viêt Nam] ; Menno D. De Jong [Viêt Nam] | Neuraminidase inhibitors and their role in avian and pandemic influenza |
001A19 | Hui-Ling Yen [États-Unis] ; Natalia A. Ilyushina [États-Unis] ; Rachelle Salomon [États-Unis] ; Erich Hoffmann [États-Unis] ; Robert G. Webster [États-Unis] ; Elena A. Govorkova [États-Unis] | Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo |
001A20 | Phillip Andrew Reece [Australie] | Neuraminidase inhibitor resistance in influenza viruses |
001B25 | Jane Democratis [Royaume-Uni] ; Manish Pareek [Royaume-Uni] ; Iain Stephenson [Royaume-Uni] | Use of neuraminidase inhibitors to combat pandemic influenza |
001B53 | Stephen M. Ford [États-Unis] ; John D. Grabenstein [États-Unis] | Pandemics, avian influenza a (H5N1), and a strategy for pharmacists |
001C12 | Samson S. Y. Wong [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] | Avian influenza virus infections in humans |
001C79 | Penelope Ward [Royaume-Uni] ; Ian Small [Royaume-Uni] ; James Smith [Suisse] ; Pia Suter [Suisse] ; Regina Dutkowski [États-Unis] | Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic |
001D99 | J. Gaillat [France] | Que penser du traitement antiviral de la grippe en l'an 2001 ? |
This area was generated with Dilib version V0.6.34. |